These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2421536)

  • 1. Augmentation of natural killer activity by neuraminidase treatment of lymphocytes from tumor-bearing mice.
    Ono M; Tanaka N
    Acta Med Okayama; 1986 Feb; 40(1):45-53. PubMed ID: 2421536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of vibrio-cholerae neuraminidase (VCN) on the NK activity of peripheral blood lymphocytes in patients with cancer].
    Ohida J
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):114-21. PubMed ID: 3379327
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Vibrio cholerae neuraminidase on the generation of cell-mediated cytotoxicity in vitro.
    Ferguson R; Anderson SM; Schmidtke JR; Simmons RL
    J Immunol; 1976 Dec; 117(6):2150-7. PubMed ID: 136474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
    Lala PK; Parhar RS; Singh P
    Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
    Young MR; Wheeler E; Newby M
    J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the synthetic preparation B 58 on the activity of natural killer and cytostatic cells of the mouse spleen].
    Malaĭtsev VV; Bogdanova IM; Spivak NIa; Bogdashin IV; Zueva VS
    Biull Eksp Biol Med; 1987 Jun; 103(6):697-9. PubMed ID: 2439142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population dynamics of natural killer cells in the spleen and bone marrow of normal and leukemic mice during in vivo exposure to interleukin-2.
    Christopher FL; Dussault I; Miller SC
    Immunobiology; 1991 Dec; 184(1):37-52. PubMed ID: 1800310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of mouse spleen natural killer (NK) cell activity by beta-interferon, interleukin-1, and prostaglandins.
    Voiculescu CL; Rosu L; Rogoz S
    Lymphology; 1988 Sep; 21(3):144-51. PubMed ID: 3264360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of natural killer activity and antibody-dependent cellular cytotoxicity in spleen cells of tumor bearing mice.
    Ono M; Tanaka N; Orita K
    Acta Med Okayama; 1983 Aug; 37(4):367-76. PubMed ID: 6605026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor immune response following injection of neuraminidase-treated sarcoma cells.
    Faraci RP; Marrone JA; Ketcham AS
    Ann Surg; 1975 Mar; 181(3):359-62. PubMed ID: 1130852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of cytotoxic responses by prostaglandin E2.
    Häcker-Shahin B; Dröge W
    Cell Immunol; 1985 Mar; 91(1):43-51. PubMed ID: 3871666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytotoxic responses by prostaglandin E2 in the presence of interleukin 2.
    Wolf M; Droege W
    Cell Immunol; 1982 Sep; 72(2):286-93. PubMed ID: 6983912
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
    Afifi MS; Bennett M; Kumar V
    Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity.
    Parhar RS; Lala PK
    Cell Immunol; 1985 Jul; 93(2):265-79. PubMed ID: 3159480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.